Synlogic, Inc(NASDAQ:SYBX) 
Synlogic, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. Its therapeutic programs include SYNB1618, an oral therapy that is in Phase II clinical trial...
Website: http://www.synlogictx.com
Founded: 2014
Full Time Employees: 76
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.10
H 1.17
L 0.98
C 1.08
V 19,814
10EMA 1.08
20EMA 1.08
60EMA 1.08
120EMA 1.08
250EMA 1.08